Latest Insider Transactions at I Teos Therapeutics, Inc. (ITOS)
This section provides a real-time view of insider transactions for I Teos Therapeutics, Inc. (ITOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of iTeos Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of iTeos Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2022
|
Detlev Biniszkiewicz Director |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$178,500
$51.9 P/Share
|
|
Jan 03
2022
|
Detlev Biniszkiewicz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$66,500
$19.0 P/Share
|
|
Jan 03
2022
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$357,000
$51.9 P/Share
|
|
Jan 03
2022
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$28,000
$4.3 P/Share
|
|
Dec 27
2021
|
Matthew Gall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-25.73%
|
$230,000
$46.45 P/Share
|
|
Dec 22
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,163
-5.36%
|
$711,172
$44.8 P/Share
|
|
Dec 22
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,663
+2.04%
|
$6,652
$4.3 P/Share
|
|
Dec 21
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,226
-10.33%
|
$845,944
$44.61 P/Share
|
|
Dec 21
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,226
+16.48%
|
$76,904
$4.3 P/Share
|
|
Dec 20
2021
|
David Hallal |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,150,000
$43.57 P/Share
|
|
Dec 20
2021
|
David Hallal |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.75%
|
$150,000
$3.63 P/Share
|
|
Dec 20
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,111
-10.44%
|
$391,773
$43.94 P/Share
|
|
Dec 20
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,111
+9.45%
|
$36,444
$4.3 P/Share
|
|
Dec 17
2021
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$287,000
$41.0 P/Share
|
|
Dec 17
2021
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$28,000
$4.3 P/Share
|
|
Dec 10
2021
|
Joanne Jenkins Lager Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$119,000
$34.5 P/Share
|
|
Dec 10
2021
|
Joanne Jenkins Lager Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+50.0%
|
$14,000
$4.3 P/Share
|
|
Dec 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,456
-0.34%
|
$642,048
$33.63 P/Share
|
|
Dec 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,456
-0.34%
|
$642,048
$33.63 P/Share
|
|
Dec 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,558
-0.34%
|
$1,074,414
$33.63 P/Share
|
|
Dec 06
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,208
-0.09%
|
$336,864
$33.76 P/Share
|
|
Dec 06
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,208
-0.09%
|
$336,864
$33.76 P/Share
|
|
Dec 06
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,083
-0.09%
|
$563,739
$33.76 P/Share
|
|
Dec 03
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,167
-0.23%
|
$705,845
$35.46 P/Share
|
|
Dec 03
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,167
-0.23%
|
$705,845
$35.46 P/Share
|
|
Dec 03
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,749
-0.23%
|
$1,181,215
$35.46 P/Share
|
|
Dec 02
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,187
-0.63%
|
$1,264,358
$34.29 P/Share
|
|
Dec 02
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,187
-0.63%
|
$1,264,358
$34.29 P/Share
|
|
Dec 02
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
62,230
-0.64%
|
$2,115,820
$34.29 P/Share
|
|
Dec 01
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,395
-0.14%
|
$421,430
$34.59 P/Share
|
|
Dec 01
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,395
-0.14%
|
$421,430
$34.59 P/Share
|
|
Dec 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,742
-0.14%
|
$705,228
$34.59 P/Share
|
|
Nov 30
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,937
-0.56%
|
$1,153,858
$34.9 P/Share
|
|
Nov 30
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,937
-0.56%
|
$1,153,858
$34.9 P/Share
|
|
Nov 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
56,801
-0.57%
|
$1,931,234
$34.9 P/Share
|
|
Nov 29
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,371
-0.17%
|
$352,614
$34.91 P/Share
|
|
Nov 29
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,371
-0.17%
|
$352,614
$34.91 P/Share
|
|
Nov 29
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,356
-0.17%
|
$590,104
$34.91 P/Share
|
|
Nov 26
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,674
-0.21%
|
$443,590
$35.76 P/Share
|
|
Nov 26
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
12,674
-0.21%
|
$443,590
$35.76 P/Share
|
|
Nov 26
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,210
-0.21%
|
$742,350
$35.76 P/Share
|
|
Nov 24
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,337
-0.39%
|
$1,308,132
$36.09 P/Share
|
|
Nov 24
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,337
-0.39%
|
$1,308,132
$36.09 P/Share
|
|
Nov 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,808
-0.4%
|
$2,189,088
$36.09 P/Share
|
|
Nov 23
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,500
-15.64%
|
$522,000
$36.08 P/Share
|
|
Nov 23
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,004
-0.32%
|
$720,144
$36.36 P/Share
|
|
Nov 23
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,004
-0.32%
|
$720,144
$36.36 P/Share
|
|
Nov 23
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,476
-0.33%
|
$1,205,136
$36.36 P/Share
|
|
Nov 22
2021
|
Michel Detheux Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,263
+14.93%
|
$195,156
$12.45 P/Share
|
|
Nov 22
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,114
-0.34%
|
$781,218
$37.49 P/Share
|